Your search returned 3 results.

Results
	1.	Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review. [electronic resource] by Smoragiewicz, M Laskin, J Wilson, D Ramsden, K Yee, J Lam, S Shaipanich, T Zhai, Y Ho, C Producer: 20141209 In: Current oncology (Toronto, Ont.) vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies. [electronic resource] by Smoragiewicz, M Bogaerts, J Calvo, E Marabelle, A Perrone, A Seymour, L Shalabi, A Siu, L L Tabernero, J Giaccone, G Producer: 20191114 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies. [electronic resource] by Nehra, J Bradbury, P A Ellis, P M Laskin, J Kollmannsberger, C Hao, D Juergens, R A Goss, G Wheatley-Price, P Hotte, S J Gelmon, K Tinker, A V Brown-Walker, P Gauthier, I Tu, D Song, X Khan, A Seymour, Lesley Smoragiewicz, M Producer: 20210902 In: Investigational new drugs vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)